Application 078943
- Type
- ANDA
- Sponsor
- PLIVA LACHEMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXALIPLATIN | OXALIPLATIN | INJECTABLE; INJECTION | 5MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxaliplatin | OXALIPLATIN | Baxter Healthcare Corporation | 21a2bb1d-d91d-4f99-97dd-cc67fe99a090 | 2023-07-20 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Sandoz Inc | ab162009-6f84-4d56-ab56-5e84409ec814 | 2023-07-11 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Qilu Pharmaceutical Co., Ltd. | e9e47f3c-9acc-44f5-b0bd-d26fe9d35d64 | 2021-10-18 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
| Oxaliplatin | OXALIPLATIN | Gland Pharma Limited | d6178bc6-9dae-413f-8f47-de75d576c5b8 | 2017-05-26 | Boxed warning, Warnings, Adverse reactions | Oxaliplatin OXALIPLATIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.